William LaFramboise

4PUBLICATIONS
25CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 28, 2026
Associations of Tumor Somatic Mutations and Genetic Alterations with Survival Outcomes in Melanoma Patients Treated with Ipilimumab.

Mohammad Ali Khaksar, Islam Eljilany, Ibrahim Yassine

|May 20, 2025
Integrative Immune Signature of Complementary Circulating and Tumoral Biomarkers Maximizes the Predictive Power of Adjuvant Immunotherapeutic Benefits in High-risk Melanoma.

Ahmad A Tarhini, Alyssa Obermayer, Sandra J Lee

|Feb 13, 2025
Intra-Tumoral CD8+:CD3+ Lymphocyte Density Ratio in Appendix Cancer Is a Tumor Volume- and Grade-Independent Predictor of Survival.

Chelsea Knotts, Hyun Park, Christopher Sherry

|Apr 10, 2019
Discrimination of low- and high-grade appendiceal mucinous neoplasms by targeted sequencing of cancer-related variants.

William A LaFramboise, Reetesh K Pai, Patti Petrosko

Pageof 1

Frequent Collaborators

2 joint publications

Islam Eljilany

1 joint publications

Ahmad A Tarhini

1 joint publications

Alyssa Obermayer

1 joint publications

Sandra J Lee